These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 28947259)

  • 1. [Hemolytic and uremic syndrome and related thrombotic microangiopathies: Treatment and prognosis].
    Rafat C; Coppo P; Fakhouri F; Frémeaux-Bacchi V; Loirat C; Zuber J; Rondeau E
    Rev Med Interne; 2017 Dec; 38(12):833-839. PubMed ID: 28947259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hemolytic and uremic syndrome and related thrombotic microangiopathies: Epidemiology, pathophysiology and clinics].
    Rafat C; Coppo P; Fakhouri F; Frémeaux-Bacchi V; Loirat C; Zuber J; Rondeau E
    Rev Med Interne; 2017 Dec; 38(12):817-824. PubMed ID: 28711159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Atypical hemolytic uremic syndrome (aHUS): new insights into pathogenesis leading to novel therapeutic approaches].
    Kistler AD
    Praxis (Bern 1994); 2016 Mar; 105(7):389-96. PubMed ID: 27005733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Thrombotic microangiopathies].
    Moulinier C; Veyradier A; Rondeau E; Coppo P;
    Rev Prat; 2013 Feb; 63(2):163-70. PubMed ID: 23513771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathology Consultation on the Diagnosis and Treatment of Thrombotic Microangiopathies (TMAs).
    Williams LA; Marques MB;
    Am J Clin Pathol; 2016 Feb; 145(2):158-65. PubMed ID: 27124904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Consensus opinion on diagnosis and management of thrombotic microangiopathy in Australia and New Zealand.
    Fox LC; Cohney SJ; Kausman JY; Shortt J; Hughes PD; Wood EM; Isbel NM; de Malmanche T; Durkan A; Hissaria P; Blombery P; Barbour TD
    Nephrology (Carlton); 2018 Jun; 23(6):507-517. PubMed ID: 29419916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical hemolytic uremic syndrome (aHUS): making the diagnosis.
    Laurence J
    Clin Adv Hematol Oncol; 2012 Oct; 10(10 Suppl 17):1-12. PubMed ID: 23187605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The revolution of monoclonal antibodies in the treatment of thrombotic microangiopathy].
    Sauvètre G; Grange S; Froissart A; Veyradier A; Coppo P; Benhamou Y
    Rev Med Interne; 2015 May; 36(5):328-38. PubMed ID: 25547956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Where are we with haemolytic uremic syndrome?
    Cavero T; Alonso M
    Med Clin (Barc); 2018 Oct; 151(8):329-335. PubMed ID: 29699703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombotic microangiopathy: current knowledge and outcomes with plasma exchange.
    Clark WF
    Semin Dial; 2012; 25(2):214-9. PubMed ID: 22309967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnosis and treatment of TMA based on Japanese clinical guides].
    Wada H; Hasegawa K; Watanabe M
    Rinsho Ketsueki; 2017; 58(7):849-856. PubMed ID: 28781284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spectrum of complement-mediated thrombotic microangiopathies: pathogenetic insights identifying novel treatment approaches.
    Riedl M; Fakhouri F; Le Quintrec M; Noone DG; Jungraithmayr TC; Fremeaux-Bacchi V; Licht C
    Semin Thromb Hemost; 2014 Jun; 40(4):444-64. PubMed ID: 24911558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of hemolytic uremic syndrome.
    Loirat C; Saland J; Bitzan M
    Presse Med; 2012 Mar; 41(3 Pt 2):e115-35. PubMed ID: 22284541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombotic microangiopathies: thrombotic thrombocytopenic purpura / hemolytic uremic syndrome.
    Polito MG; Kirsztajn GM
    J Bras Nefrol; 2010; 32(3):303-15. PubMed ID: 21103695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural history of thrombotic thrombocytopenic purpura and hemolytic uremic syndrome.
    Wada H; Matsumoto T; Yamashita Y
    Semin Thromb Hemost; 2014 Nov; 40(8):866-73. PubMed ID: 25377323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hemolytic uremic syndrome: clinical picture and bacterial connection.
    Parsonnet J; Griffin PM
    Curr Clin Top Infect Dis; 1993; 13():172-87. PubMed ID: 8397909
    [No Abstract]   [Full Text] [Related]  

  • 17. [Thrombotic microangiopathy : Relevant new aspects for intensive care physicians].
    Gaggl M; Aigner C; Sunder-Plassmann G; Schmidt A
    Med Klin Intensivmed Notfmed; 2016 Jun; 111(5):434-9. PubMed ID: 27255224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An update for atypical haemolytic uraemic syndrome: diagnosis and treatment. A consensus document.
    Campistol JM; Arias M; Ariceta G; Blasco M; Espinosa L; Espinosa M; Grinyó JM; Macía M; Mendizábal S; Praga M; Román E; Torra R; Valdés F; Vilalta R; Rodríguez de Córdoba S
    Nefrologia; 2015; 35(5):421-47. PubMed ID: 26456110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical hemolytic uremic syndrome: what is it, how is it diagnosed, and how is it treated?
    Nester CM; Thomas CP
    Hematology Am Soc Hematol Educ Program; 2012; 2012():617-25. PubMed ID: 23233643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Thrombotic microangiopathy: when time is the key factor!].
    Hemett OM; Martins F; Descombes E; Betticher D; Hayoz D
    Rev Med Suisse; 2014 Apr; 10(425):794, 796-803. PubMed ID: 24791425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.